Author: Mukuntha Subburayan
Targeting CNS cells Key to Abrogate MS Progression
Prof. Tony Traboulsee talks to Physician’s Weekly about his study of tolebrutinib Presented at the...
Read MoreNew Data Stand Out for Health-Related Quality of Life in mRCC
Although the CheckMate-9ER trial, comparing cabozantinib plus nivolumab to sunitinib in frontline metastatic renal cell carcinoma (mRCC), had recently demonstrated improved progression-free survival (PFS) and overall survival...
Read MoreAAN 2021: Significant Discrepancy Found in General vs Neuroradiologists MRI Reporting of MS
Management of patients with multiple sclerosis (MS) in the era of disease modifying therapies (DMT) relies heavily on magnetic resonance imaging (MRI) and the support of dedicated multidisciplinary teams (MDTs). While decisions...
Read More
Take Our PhysQuiz on Allergic Asthma
Are you caught up on advancements in treating allergic asthma? Test your knowledge on our...
Read More
Take Our PhysQuiz on Chronic Urticaria
Are you caught up on advancements in treating chronic idiopathic uriticaria (CIU)? Test your...
Read More2021 AAN Annual Meeting Kick-Off!
Due to the COVID-19 pandemic, the 2021 American Academy of Neurology Annual Meeting, the world’s premier neurology meeting, will be held in a fully virtual format from April 17-22. It will include: Over 90 expert-led CME...
Read MoreAAN 2021: Identifying distinct cognitive phenotypes in multiple sclerosis
Cognitive impairment is a common and disabling feature of multiple sclerosis (MS), but a precise characterization of cognitive phenotypes in MS patients is still lacking. This study identified five cognitive phenotypes:...
Read MoreAAN 2021: Disability Accrual in Primary Progressive & Secondary Progressive Multiple Sclerosis
The study team compared disability accrual in primary and secondary progressive multiple sclerosis (PPMS, SPMS) in the international MSBase cohort, using multivariable survival models, and applying objective diagnostic criteria...
Read MoreAAN 2021: Dual Tasking In Patients With MS
Patients with MS may have difficulty performing double task (DT) while walking or causing interference. More research is needed in order to define the role of disability degree in the severity of the interference produced in the...
Read MoreAAN 2021: Influencing And Optimizing The Management Of Patients With MS
Management of patients with multiple sclerosis (MS) in the era of disease modifying therapies (DMT) relies heavily on magnetic resonance imaging (MRI). As physicians, decisions are influenced by the reporting prowess of...
Read MoreLaser Therapy for COVID-19; Vaccine Hesitancy; Advances in Gyn Cancer Prevention
FEATURE: Laser Therapy Successful Against COVID-19 Pneumonia [Minute 2:15] [spreaker type=player resource=”episode_id=44175625″ theme=”light” autoplay=”false” playlist=”false”...
Read More
PW Podcast: “Genetic Patch” for Deafness; Physician Liability with Pre-Existing Conditions; Osteo Fractures Economic Impact
Episode Segments: FEATURE: Eggshell Skull and Pre-Existing Conditions [Minute 21:30] How the law...
Read More
Guideline for Diagnosis and Management of Chronic Spontaneous Urticaria
Chronic spontaneous urticaria (CSU) can be a debilitating condition that can significantly affect...
Read MoreMaybe We’re Not All Hanging in There. And That’s OK
A s a palliative care doctor in NYC during the beginning of the pandemic, my typical greeting response of “I’m fine” was speedily replaced with “I’m hanging in there.” It seemed slightly less false (because who’s really “fine”...
Read More
Don’t Assume MS Causes All Changes in Patients’ Disability
As the average age of people with multiple sclerosis (MS) increases, it becomes even more critical...
Read More
Disability Changes in Older Patients with MS May Not be MS-Related
As the average age of people with multiple sclerosis (MS) increases, it becomes even more critical...
Read More
Lesion State Modulates Link Between sNfL & Age in Multiple Sclerosis
Prior research has shown that levels of serum neurofilament light (sNfL), a promising biomarker of...
Read MorePediatric-Onset MS and Social Consequences
Pediatric-onset MS (PoMS) is associated with less educational achievement, lower earnings, and greater use of disability benefits throughout the working-age life span, according to a study published in JAMA Neurology....
Read More